Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03439865 · ClinicalTrials.gov registry record · Early Phase 1
Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis
A Early Phase 1 study of Chronic Rhinosinusitis (Diagnosis), sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03439865 is a Early Phase 1 study of Chronic Rhinosinusitis (Diagnosis) that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 20 participants, below the 88-participant average among 9 other Chronic Rhinosinusitis (Diagnosis) trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03439865, a Early Phase 1 study of Chronic Rhinosinusitis (Diagnosis), is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this pilot study is to explore wither ivacaftor in refractory CRS patients will demonstrate safety and tolerability; restore CFTR-mediated Cl- secretions as measured by EDSPD testing; produce detectable improvements in validated measures of CRS including the SNOT-22 questionnaire, Lund-MacKay CT scan grading, and Lund-Kennedy endoscopic scores; and provide beneficial effects on readily measured markers of sinonasal inflammation and infection (IP-10, IL-8, and Pseudomonas CFUs).
Conditions Studied
Interventions
- DRUG Ivacaftor
- DRUG standard of care treatment
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-05-02 |
| Est. Completion | 2026-04 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03439865
The ClinicalTrials.gov registry entry for NCT03439865 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 88-participant average among 9 other Chronic Rhinosinusitis (Diagnosis) trials with a reported enrollment target (77% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Rhinosinusitis (Diagnosis) appearing as the primary indexed condition, and to 2 interventions - of which Ivacaftor is the first listed.
NCT03439865 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT03439865 about?
NCT03439865 is a clinical study titled "Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis". The purpose of this pilot study is to explore wither ivacaftor in refractory CRS patients will demonstrate safety and tolerability; restore CFTR-mediated Cl- secretions as measured by EDSPD testing; produce detectable improvements in validated measures of CRS including the SNOT-22 questionnaire, Lun...
What is the current status of trial NCT03439865?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2019-05-02. Estimated completion is 2026-04.
What conditions does trial NCT03439865 study?
This clinical trial studies the following conditions: Chronic Rhinosinusitis (Diagnosis).
What interventions are being tested in trial NCT03439865?
The interventions under investigation include: Ivacaftor (DRUG), standard of care treatment (DRUG).
Who is sponsoring clinical trial NCT03439865?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03439865 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Rhinosinusitis (Diagnosis)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Role of IL5 in Epithelial Cell Integrity
RECRUITING · Early Phase 1
-
Sinus Disease in Young Children With Cystic Fibrosis
RECRUITING
-
Topical Probiotic Sinus Irrigations for Treating Chronic Sinusitis
RECRUITING · Phase 2
-
Impact of Sinus Surgery on Individuals With Cystic Fibrosis
RECRUITING
-
The Sinonasal Microbiome
ACTIVE NOT RECRUITING
-
Functional Endoscopic Sinus Surgery Study
ACTIVE NOT RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.